These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19126808)
21. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate]. Berenguer Sánchez A Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304 [No Abstract] [Full Text] [Related]
22. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of prostate cancer]. Romics I Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076 [No Abstract] [Full Text] [Related]
25. The role of hormonal treatment in prostate cancer. Flüchter SH; Weiser R; Gamper C Recent Results Cancer Res; 2007; 175():211-37. PubMed ID: 17432562 [TBL] [Abstract][Full Text] [Related]
26. The benefits of early androgen blockade. Maroni PD; Crawford ED Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789 [TBL] [Abstract][Full Text] [Related]
27. Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance. Kelly WK; Slovin S; Scher HI Urol Clin North Am; 1997 May; 24(2):421-31. PubMed ID: 9126240 [TBL] [Abstract][Full Text] [Related]
28. Overview of hormonal therapy for prostate cancer. Carter HB; Isaacs JT Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039 [No Abstract] [Full Text] [Related]
33. Multiple intracrine hormonal targets in the prostate: opportunities and challenges. Labrie F BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360 [No Abstract] [Full Text] [Related]
34. [Neoadjuvant hormonal treatment combined with external irradiation in the management of prostate cancer]. Bolla M; Artignan X; Fourneret P; Brochon D; Ringeisen F; Descotes JL Bull Cancer; 2006 Nov; 93(11):1101-5. PubMed ID: 17145579 [TBL] [Abstract][Full Text] [Related]
35. Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer. Suzuki T; Bruchovsky N; Aihara K Philos Trans A Math Phys Eng Sci; 2010 Nov; 368(1930):5045-59. PubMed ID: 20921011 [TBL] [Abstract][Full Text] [Related]
37. The androgen receptor for the radiation oncologist. Quero L; Rozet F; Beuzeboc P; Hennequin C Cancer Radiother; 2015 May; 19(3):220-7. PubMed ID: 25921704 [TBL] [Abstract][Full Text] [Related]
38. [Evolution of endocrine therapy for prostate cancer]. Igawa T; Saito Y Nihon Rinsho; 2000 Jul; 58 Suppl():176-81. PubMed ID: 11022709 [No Abstract] [Full Text] [Related]
39. Prostate cancer drugs. Making sense of the options. Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308 [No Abstract] [Full Text] [Related]